225 filings
Page 2 of 12
8-K
uja9rup4jz5
7 Nov 22
Haemonetics Reports Second Quarter and First Half Fiscal 2023 Results; Updates Fiscal 2023 Guidance
6:03am
8-K
rvtwlat3ht8r pc2
19 Oct 22
Departure of Directors or Certain Officers
5:15pm
8-K
zkeqv
10 Aug 22
Haemonetics Reports First Quarter Fiscal 2023 Results; Updates Fiscal 2023 Guidance; Announces New $300 Million Share Repurchase Authorization
12:00am
8-K
r9e9x3ut4r7v1k5596mu
8 Aug 22
Departure of Directors or Certain Officers
5:04pm
8-K
gi56goxa2ityifnaepre
1 Aug 22
Entry into a Material Definitive Agreement
4:11pm
8-K
tbkxzwp lxpcmjqeyel
16 Jun 22
Departure of Directors or Certain Officers
4:18pm
8-K
q73 bv7fom
25 May 22
Departure of Directors or Certain Officers
6:14am
8-K
ksma3b95yf6obk81a
10 May 22
Results of Operations and Financial Condition
6:08am
8-K
0goaa
21 Mar 22
Departure of Directors or Certain Officers
4:45pm
8-K
770csmu
15 Feb 22
Regulation FD Disclosure
6:48am
8-K
grl07su
8 Feb 22
Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2022 Results; Updates Fiscal 2022 Guidance
6:25am
8-K
sqev8iovyaiin0ag
9 Nov 21
Haemonetics Reports Second Quarter and 1st Half Fiscal 2022 Results; Updates Fiscal 2022 Guidance
6:03am
8-K
13xug ed18iixa
11 Aug 21
Results of Operations and Financial Condition
6:12am
8-K
ixkjf 1ojcg2d3h321uj
9 Aug 21
Submission of Matters to a Vote of Security Holders
4:26pm
8-K
k6pmye
21 May 21
Departure of Directors or Certain Officers
6:23am
8-K
begwc4b
13 May 21
Results of Operations and Financial Condition
6:10am
8-K
wphml r6m7901flcec4j
19 Apr 21
Other Events
6:05am
8-K
w6t4z
16 Mar 21
Entry into a Material Definitive Agreement
4:30pm
8-K
z9xdkvu7zbmspwuz 3g
5 Mar 21
Entry into a Material Definitive Agreement
4:30pm
8-K
e2y202v3 cy
2 Mar 21
Haemonetics Prices $435.0 Million Convertible Senior Notes Offering
9:37pm